MyomiRNAs Dysregulation in ALS Rehabilitation.
ALS
ALS rehabilitation
circulating miRNAs
motor neuron
muscle
myomiRs
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
10 Jan 2019
10 Jan 2019
Historique:
received:
26
10
2018
revised:
21
12
2018
accepted:
05
01
2019
entrez:
13
1
2019
pubmed:
13
1
2019
medline:
13
1
2019
Statut:
epublish
Résumé
Amyotrophic lateral sclerosis (ALS) is a rare, progressive, neurodegenerative disorder caused by degeneration of upper and lower motor neurons. The disease process leads, because of lower motor neuron involvement, to progressive muscle atrophy, weakness, and fasciculations and for the upper motor neuron involvement leads to spasticity. Muscle atrophy in ALS is caused by a neural dysregulation in the molecular network controlling fast and slow muscle fibers. Denervation and reinnervation processes in skeletal muscle occur in the course of ALS and are modulated by rehabilitation. MicroRNAs (miRNAs) are small, non-coding RNAs that are involved in different biological functions under various pathophysiological conditions. MiRNAs can be secreted by various cell types and they are markedly stable in body fluids. MiR-1, miR-133 a miR-133b, and miR-206 are called "myomiRs" and are considered markers of myogenesis during muscle regeneration and contribute to neuromuscular junction stabilization or sprouting. We observed a positive effect of a standard aerobic exercise rehabilitative protocol conducted for six weeks in 18 ALS patients during hospitalization in our center. This is a preliminary study, in which we correlated clinical scales with molecular data on myomiRs. After six weeks of moderate aerobic exercise, we found lower levels in serum of myomiRNAs. Our data suggest that circulating miRNAs changed during skeletal muscle recovery in response to physical rehabilitation in ALS. However, no firm conclusions can be made on the ALS-specific effect of exercise on miRNA levels.
Identifiants
pubmed: 30634563
pii: brainsci9010008
doi: 10.3390/brainsci9010008
pmc: PMC6356197
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurol Sci. 1999 Oct 31;169(1-2):69-75
pubmed: 10540010
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Neurol Sci. 2001 Oct 15;191(1-2):133-7
pubmed: 11677004
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
Nat Genet. 2006 Feb;38(2):228-33
pubmed: 16380711
Neurology. 2007 Jun 5;68(23):2003-7
pubmed: 17548549
Biochim Biophys Acta. 2008 Nov;1779(11):682-91
pubmed: 18381085
Amyotroph Lateral Scler. 2009 Aug;10(4):205-9
pubmed: 19267274
Science. 2009 Dec 11;326(5959):1549-54
pubmed: 20007902
Amyotroph Lateral Scler. 2010 May 3;11(3):289-92
pubmed: 20433412
Int J Biochem Cell Biol. 2010 Aug;42(8):1252-5
pubmed: 20619221
J Physiol. 2010 Oct 15;588(Pt 20):4029-37
pubmed: 20724368
J Mol Neurosci. 2011 Mar;43(3):470-7
pubmed: 21057983
Cell Cycle. 2011 Feb 1;10(3):441-8
pubmed: 21270519
Nat Rev Neurol. 2011 Nov;7(11):616-30
pubmed: 22051914
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):653-73
pubmed: 22938880
Anal Biochem. 2012 Dec 1;431(1):69-75
pubmed: 22982505
Curr Opin Clin Nutr Metab Care. 2013 May;16(3):258-66
pubmed: 23449000
Nat Rev Neurosci. 2013 Apr;14(4):248-64
pubmed: 23463272
J Physiol. 2013 Sep 15;591(18):4637-53
pubmed: 23798494
Vet Pathol. 2014 Jul;51(4):759-74
pubmed: 24045890
Front Physiol. 2013 Dec 18;4:356
pubmed: 24391590
PLoS One. 2014 Feb 20;9(2):e89065
pubmed: 24586506
Ultrastruct Pathol. 2014 Oct;38(5):295-302
pubmed: 25079897
Front Neurosci. 2014 Aug 14;8:252
pubmed: 25177267
Clin Chem. 2015 Jan;61(1):56-63
pubmed: 25391989
CNS Neurol Disord Drug Targets. 2015;14(2):194-207
pubmed: 25613506
Int J Biol Sci. 2015 Feb 05;11(3):345-52
pubmed: 25678853
PLoS One. 2015 Jun 01;10(6):e0128560
pubmed: 26030275
J Neurol. 2016 Jan;263(1):52-60
pubmed: 26477027
Clin Neuropathol. 2016 Jan-Feb;35(1):22-30
pubmed: 26588026
Mol Cell Neurosci. 2016 Mar;71:34-45
pubmed: 26704906
Dev Biol. 2016 Feb 1;410(1):1-13
pubmed: 26708096
Biomed Res Int. 2016;2016:5930621
pubmed: 27195289
J Neuromuscul Dis. 2015;2(1):1-11
pubmed: 27547731
Nature. 2016 Nov 10;539(7628):197-206
pubmed: 27830784
N Engl J Med. 2017 Jul 13;377(2):162-172
pubmed: 28700839
J Neurol Sci. 2017 Sep 15;380:58-63
pubmed: 28870590
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):250-258
pubmed: 29191052
Life Sci. 2018 Jan 15;193:110-123
pubmed: 29241710
Eur J Transl Myol. 2018 Mar 23;28(1):7278
pubmed: 29686818
Int J Mol Sci. 2018 May 22;19(5):null
pubmed: 29786645
Lancet Neurol. 2018 Jul;17(7):579
pubmed: 29914701
Noncoding RNA Res. 2018 Jul 31;3(3):154-159
pubmed: 30175288
Front Neurosci. 2018 Sep 05;12:625
pubmed: 30233304
Neurology. 1995 Apr;45(4):733-40
pubmed: 7723963
Arch Phys Med Rehabil. 1993 Jul;74(7):711-5
pubmed: 8328892
Ann Neurol. 1996 Feb;39(2):147-57
pubmed: 8967745